Gilead Sciences (NASDAQ:GILD) reported quarterly earnings results on February 10, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of…
Gilead Sciences (NASDAQ:GILD) reported quarterly earnings results on February 10, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $1.86, beating the consensus estimate of $1.83 by $0.03 per share. Revenue came in at $7.9B, beating the estimate of $7.6B.
Gilead Sciences's stock moved following the earnings release. The stock currently trades at $152.57 with a market capitalization of $152.9B.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NASDAQ · GILD
$151.37
Down: -$0.45 · -0.30%
Live quote updated
Keep reading
institutional ·
institutional ·
analyst ·
analyst ·
